TORONTO, May 29, 2019 /CNW/ - Khiron Life Sciences
Corp. ("Khiron" or the "Company") (TSXV:KHRN,
OTCQB:KHRNF), a cannabis company with core operations in Latin
America is pleased to announce today its addition to the
MJ ETFMG Alternative Harvest ETF (NYSE:MJ) (the "Fund"), a fund
with approximately US$1.22 billion in
assets currently under management. This represents an important
development for the Company as it advances its strategy as a Latin
American cannabis company with global growth.
The Fund tracks the Prime Alternative Harvest Index, designed to
measure the performance of companies within the cannabis ecosystem
benefiting from global medicinal and recreational cannabis
legalization. The Fund seeks to provide investment results that,
before fees and expenses, correspond generally to the price and
yield performance of the Prime Alternative Harvest Index.
As at May 28, 2019, the Fund held
approximately 4.2 million Khiron Life Sciences common shares. A
rebalancing of the Fund occurs each calendar quarter. The holdings
of MJ ETFMG Alternative Harvest and its current portfolio weights
are regularly updated and available at www.etfmj.com.
About Khiron Life Sciences Corp.
Khiron Life Sciences Corp. is positioned to be the dominant
integrated cannabis company in Latin
America. Khiron has core operations in Latin America and is fully licensed in
Colombia for the cultivation,
production, domestic distribution, and international export of both
tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis.
In May 2018, Khiron listed on the
TSXV, becoming the first Colombian based medical cannabis company
to trade on any exchange globally.
With a focused regional strategy and patient oriented
approach, the Company combines global scientific expertise,
agricultural advantages, branded product market entrance
experience and education to drive prescription and brand
loyalty to address priority medical conditions such as chronic
pain, epilepsy, depression and anxiety in the Latin American
market of over 620 million people. The Company is led by Co-founder
and Chief Executive Officer, Alvaro
Torres, together with an experienced executive team,
and a knowledgeable Board of Directors that includes former
President of Mexico, Vicente Fox.
To be added to the distribution list, please email
khiron@kcsa.com with "Khiron" in the subject line.
Forward-looking statements
This news release may contain "forward-looking information"
and "forward-looking statements" within the meaning of applicable
Canadian securities legislation. All information contained herein
that is not historical in nature may constitute forward-looking
information. Forward-looking statements herein include but are not
limited to statements regarding the final acceptance of the TSXV
and the intended use of proceeds, and are necessarily based upon a
number of assumptions that, while considered reasonable by
management, are inherently subject to business, market and economic
risks, uncertainties and contingencies that may cause actual
results, performance or achievements to be materially different
from those expressed or implied by forward-looking statements.
Except as required by law, the Company disclaims any obligation to
update or revise any forward-looking statements. Readers are
cautioned not to put undue reliance on these forward-looking
statements.
United States Disclaimer
This news release
does not constitute an offer to sell or a solicitation of an offer
to buy any of the securities in the United States. The securities have not been
and will not be registered under the United States Securities Act
of 1933, as amended (the "U.S. Securities Act") or any state
securities laws and may not be offered or sold within the
United Statesor to U.S. Persons (as such term is defined in
Regulation S under the U.S. Securities Act) unless registered under
the U.S. Securities Act and applicable state securities laws or an
exemption from such registration is available
Neither the TSXV nor its Regulation Services Provider (as
that term is defined in the policies of the TSXV) accepts
responsibility for the adequacy or accuracy of this press
release.
Further information in respect of the Company can be found
at www.khiron.ca.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/khiron-announces-addition-to-1-2b-mj-etfmg-alternative-harvest-etf-300857930.html
SOURCE Khiron Life Sciences Corp.